↓ Skip to main content

Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus

Overview of attention for article published in Drug Safety, October 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
85 Mendeley
Title
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus
Published in
Drug Safety, October 2019
DOI 10.1007/s40264-019-00857-8
Pubmed ID
Authors

Kohei Kaku, Koichi Kisanuki, Mari Shibata, Takashi Oohira

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 13%
Student > Master 9 11%
Researcher 8 9%
Student > Ph. D. Student 6 7%
Lecturer 4 5%
Other 13 15%
Unknown 34 40%
Readers by discipline Count As %
Medicine and Dentistry 15 18%
Pharmacology, Toxicology and Pharmaceutical Science 10 12%
Biochemistry, Genetics and Molecular Biology 6 7%
Immunology and Microbiology 4 5%
Nursing and Health Professions 4 5%
Other 10 12%
Unknown 36 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2019.
All research outputs
#20,585,941
of 23,172,045 outputs
Outputs from Drug Safety
#1,645
of 1,711 outputs
Outputs of similar age
#307,136
of 361,453 outputs
Outputs of similar age from Drug Safety
#21
of 21 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,711 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,453 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.